NAVB
Vanguard Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-276,491
| Closed | -$24.8K | – | 4605 |
|
|
2023
Q3 | $24.8K | Hold |
276,491
| – | – | ﹤0.01% | 4481 |
|
|
2023
Q2 | $25.4K | Sell |
276,491
-10,147
| -4% | -$934 | ﹤0.01% | 4507 |
|
|
2023
Q1 | $74.5K | Sell |
286,638
-381,102
| -57% | -$99.1K | ﹤0.01% | 4427 |
|
|
2022
Q4 | $140K | Sell |
667,740
-45,389
| -6% | -$9.53K | ﹤0.01% | 4352 |
|
|
2022
Q3 | $181K | Sell |
713,129
-23,794
| -3% | -$6.04K | ﹤0.01% | 4432 |
|
|
2022
Q2 | $530K | Hold |
736,923
| – | – | ﹤0.01% | 4279 |
|
|
2022
Q1 | $582K | Hold |
736,923
| – | – | ﹤0.01% | 4362 |
|
|
2021
Q4 | $737K | Sell |
736,923
-1,438
| -0.2% | -$1.44K | ﹤0.01% | 4348 |
|
|
2021
Q3 | $1.29M | Buy |
738,361
+8,600
| +1% | +$15K | ﹤0.01% | 4188 |
|
|
2021
Q2 | $1.34M | Hold |
729,761
| – | – | ﹤0.01% | 4089 |
|
|
2021
Q1 | $1.47M | Hold |
729,761
| – | – | ﹤0.01% | 3928 |
|
|
2020
Q4 | $1.57M | Sell |
729,761
-13,298
| -2% | -$28.6K | ﹤0.01% | 3718 |
|
|
2020
Q3 | $2.01M | Buy |
743,059
+332,549
| +81% | +$898K | ﹤0.01% | 3485 |
|
|
2020
Q2 | $1.62M | Buy |
410,510
+10,432
| +3% | +$41.1K | ﹤0.01% | 3494 |
|
|
2020
Q1 | $305K | Buy |
400,078
+193,644
| +94% | +$148K | ﹤0.01% | 3786 |
|
|
2019
Q4 | $260K | Hold |
206,434
| – | – | ﹤0.01% | 3907 |
|
|
2019
Q3 | $143K | Buy |
206,434
+26,449
| +15% | +$18.3K | ﹤0.01% | 3996 |
|
|
2019
Q2 | $114K | Sell |
179,985
-3,813,935
| -95% | -$2.42M | ﹤0.01% | 4041 |
|
|
2019
Q1 | $552K | Buy |
3,993,920
+266,108
| +7% | +$36.8K | ﹤0.01% | 3752 |
|
|
2018
Q4 | $383K | Sell |
3,727,812
-1,367,551
| -27% | -$141K | ﹤0.01% | 3784 |
|
|
2018
Q3 | $1.17M | Buy |
5,095,363
+11,859
| +0.2% | +$2.73K | ﹤0.01% | 3686 |
|
|
2018
Q2 | $1.16M | Sell |
5,083,504
-58,379
| -1% | -$13.3K | ﹤0.01% | 3649 |
|
|
2018
Q1 | $1.85M | Sell |
5,141,883
-28,390
| -0.5% | -$10.2K | ﹤0.01% | 3486 |
|
|
2017
Q4 | $1.85M | Buy |
5,170,273
+252,738
| +5% | +$90.6K | ﹤0.01% | 3449 |
|
|
2017
Q3 | $2.04M | Buy |
4,917,535
+29,792
| +0.6% | +$12.4K | ﹤0.01% | 3391 |
|
|
2017
Q2 | $2.49M | Buy |
4,887,743
+80,499
| +2% | +$41K | ﹤0.01% | 3320 |
|
|
2017
Q1 | $2.77M | Buy |
4,807,244
+253,216
| +6% | +$146K | ﹤0.01% | 3276 |
|
|
2016
Q4 | $2.86M | Buy |
4,554,028
+172,928
| +4% | +$109K | ﹤0.01% | 3239 |
|
|
2016
Q3 | $4.01M | Sell |
4,381,100
-70,191
| -2% | -$64.3K | ﹤0.01% | 3115 |
|
|
2016
Q2 | $2.36M | Sell |
4,451,291
-400,584
| -8% | -$213K | ﹤0.01% | 3324 |
|
|
2016
Q1 | $4.58M | Buy |
4,851,875
+7,663
| +0.2% | +$7.24K | ﹤0.01% | 2997 |
|
|
2015
Q4 | $6.44M | Buy |
4,844,212
+61,626
| +1% | +$82K | ﹤0.01% | 2868 |
|
|
2015
Q3 | $10.9M | Buy |
4,782,586
+210,918
| +5% | +$481K | ﹤0.01% | 2562 |
|
|
2015
Q2 | $7.36M | Buy |
4,571,668
+56,950
| +1% | +$91.7K | ﹤0.01% | 2825 |
|
|
2015
Q1 | $7.18M | Buy |
4,514,718
+302,976
| +7% | +$482K | ﹤0.01% | 2812 |
|
|
2014
Q4 | $7.96M | Buy |
4,211,742
+87,473
| +2% | +$165K | ﹤0.01% | 2646 |
|
|
2014
Q3 | $5.44M | Sell |
4,124,269
-93,674
| -2% | -$124K | ﹤0.01% | 2778 |
|
|
2014
Q2 | $6.24M | Buy |
4,217,943
+141,514
| +3% | +$209K | ﹤0.01% | 2730 |
|
|
2014
Q1 | $7.54M | Buy |
4,076,429
+136,662
| +3% | +$253K | ﹤0.01% | 2620 |
|
|
2013
Q4 | $8.16M | Buy |
3,939,767
+123,932
| +3% | +$257K | ﹤0.01% | 2550 |
|
|
2013
Q3 | $10.1M | Buy |
3,815,835
+686,988
| +22% | +$1.82M | ﹤0.01% | 2392 |
|
|
2013
Q2 | $8.35M | Buy |
+3,128,847
| New | +$8.35M | ﹤0.01% | 2407 |
|